Rheumatoid arthritis patients regularly receive prescriptions for a family of medications known as disease-modifying antirheumatic medicines (DMARDs). Some of these drugs are also used to treat psoriatic arthritis, ankylosing spondylitis, and systemic lupus erythematosus.
Antirheumatic drugs alter the course of the illness to reduce swelling and discomfort, decrease or stop joint degeneration, and preserve the structure and functionality of the joints.
Click Here to Get a Sample Copy @ https://www.coherentmarketinsights.com/insight/request-sample/5185
According to predictions, the market for disease-modifying antirheumatic medicines (DMARDs) would increase at a CAGR of 3.5% over the following five years, reaching US$ 20,671.1 million in 2022.
Rising rheumatoid arthritis prevalence is predicted to drive market development over the forecasted period.
The worldwide market for disease-modifying antirheumatic drugs (DMARD) is anticipated to develop during the forecast period as rheumatoid arthritis prevalence rises. For instance, the yearly incidence of RA (rheumatoid arthritis) in the United States and other western countries of northern Europe is around 40 per 100,000 people, according to statistics published by the National Center for Biotechnology Information in June 2022.
Over the course of the forecast period, rising product introductions for the treatment of rheumatoid arthritis, psoriasis, etc., are anticipated to fuel market expansion.
The growth of the worldwide disease-modifying antirheumatic drug (DMARD) market is anticipated to be driven by rising product introductions for the treatment of psoriasis and rheumatoid arthritis over the projected period.
For instance, the introduction of RediTrex injectable was announced by Cumberland Pharmaceuticals Inc., a specialised pharmaceutical firm in the United States, in November 2020. A new brand of pre-filled syringes called RediTrex was created with the goal of making it simple to administer methotrexate subcutaneously to those with psoriasis and rheumatoid arthritis.
Impact of Coronavirus
The forced quarantine and scarcity of manpower during the COVID-19 pandemic have significantly affected the availability of raw materials needed for the creation of medications. Transporting raw materials across areas is impossible due to the unreliable connection between regional warehouses. The global market for intraocular melanoma therapy has been adversely impacted by this paucity of raw materials and components. Therefore, it is anticipated that the COVID-19 pandemic would negatively affect the market for disease-modifying antirheumatic drugs. According to a June 2021 article in the journal Exploratory Research in Clinical and Social Pharmacy, a research was conducted to determine how COVID-19 might affect the pharmaceutical systems and supply chain in Sub-Saharan nations with low resources. This study found a detrimental effect on the accessibility and availability of necessary medications, hygiene and sanitation supplies, and antimicrobials. Due to a decline in the shipping of pharmaceutical products across national borders and a reduction in local production capacity, the majority of pharmaceutical enterprises and pharmacies in Namibia faced delays in the manufacturing and delivery of pharmaceuticals. For instance, the COVID-19 pandemic has significantly impacted global medicine shortages and manufacturing prices, according to a review report that was published in the European Pharmaceutical Review journal in November 2020. Additionally, according to the same source, the COVID-19 pandemic has caused issues with medicine stockpiling, delayed transit, and other issues. Next-generation technologies, such as digital network platforms created to function across numerous pharmaceutical firms and assure the prompt distribution of medications to patients throughout the world, are some measures that may be adopted to ease the supply of pharmaceuticals during the pandemic.
The negative effects of disease-modifying antirheumatic drugs are one of the main problems impeding the growth of the worldwide disease-modifying antirheumatic drug (DMARD) industry. The anti-inflammatory drug azathioprine (Imuran) is used to treat several inflammatory diseases, including RA. The most frequent adverse effects are nausea and vomiting, occasionally coupled with diarrhoea and stomach discomfort. A higher risk of cancer is linked to azathioprine long-term usage.
Ask For Discount Before Purchasing This Business Report : https://www.coherentmarketinsights.com/insight/request-discount/5185
Reasons to buy this Disease-Modifying Antirheumatic Drug (DMARD) Market Report
☑ It attempts an analysis of the competing scenario.
☑ The current and exceptional product revenue market.
☑ An in-depth data on the regional investigation and competitive landscape structure.
☑ It benefits in creating an awareness of the important key product segments.
☑ The marketing strategies, opportunities, and development factors are explained.
☑ Disease-Modifying Antirheumatic Drug (DMARD) market size estimation and recent advancements in the industry are explained.
The Study Objectives are:
✔ A comprehensive insight into key players operating in the Disease-Modifying Antirheumatic Drug (DMARD) Market and their corresponding data.
✔ It includes product portfolio, annual revenue, expenditure on research and development, geographical presence, key developments in recent years, and growth strategies.
✔ Regional analysis, which includes insight into the dominant market and corresponding market share.
✔ It also includes various socio-economic factors affecting the evolution of the market in the region.
✔ The report offers a comprehensive insight into different individuals from value chains such as raw materials suppliers, distributors, and stockholders.
Table of Content
Chapter 1 Industry Overview
1.3 Research Scope
1.4 Market Analysis by Regions
1.5 Disease-Modifying Antirheumatic Drug (DMARD) Market Size Analysis from 2022 to 2028
11.6 COVID-19 Outbreak: Disease-Modifying Antirheumatic Drug (DMARD) Industry Impact
Chapter 2 Global Disease-Modifying Antirheumatic Drug (DMARD) Competition by Types, Applications, and Top Regions and Countries
2.1 Global Disease-Modifying Antirheumatic Drug (DMARD) (Volume and Value) by Type
2.3 Global Disease-Modifying Antirheumatic Drug (DMARD) (Volume and Value) by Regions
Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.2 Regional Production Market Analysis
Chapter 4 Global Disease-Modifying Antirheumatic Drug (DMARD) Sales, Consumption, Export, Import by Regions (2017-2022)
Chapter 5 North America Disease-Modifying Antirheumatic Drug (DMARD) Market Analysis
Chapter 6 East Asia Disease-Modifying Antirheumatic Drug (DMARD) Market Analysis
Chapter 7 Europe Disease-Modifying Antirheumatic Drug (DMARD) Market Analysis
Chapter 8 South Asia Disease-Modifying Antirheumatic Drug (DMARD) Market Analysis
Chapter 9 Southeast Asia Disease-Modifying Antirheumatic Drug (DMARD) Market Analysis
Chapter 10 Middle East Disease-Modifying Antirheumatic Drug (DMARD) Market Analysis
Chapter 11 Africa Disease-Modifying Antirheumatic Drug (DMARD) Market Analysis
Chapter 12 Oceania Disease-Modifying Antirheumatic Drug (DMARD) Market Analysis
Chapter 13 South America Disease-Modifying Antirheumatic Drug (DMARD) Market Analysis
Chapter 14 Company Profiles and Key Figures in Disease-Modifying Antirheumatic Drug (DMARD) Business
Chapter 15 Global Disease-Modifying Antirheumatic Drug (DMARD) Market Forecast (2022-2028)
Chapter 16 Conclusions
Buy This Complete Business Report @ https://www.coherentmarketinsights.com/insight/buy-now/5185
Customization of the Report
Our research analysts will help you to get customized details for your report, which can be modified in terms of a specific region, application or any statistical details. In addition, we are always willing to comply with the study, which triangulated with your own data to make the market research more comprehensive in your perspective.
Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027